Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.56 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.45 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.45 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29898298 | 1.00 | HTT (0.56) | HTTHCAR1POLBFGFR1ALDH1A1 | |
| SCHEMBL3417306 | 0.86 | HTT (0.73) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL24179153 | 0.85 | FGFR1 (0.51) | HTTHCAR1POLBFGFR1ALDH1A1 | |
| SCHEMBL22188457 | 0.81 | HTT (0.56) | HTTPOLBFGFR1ROCK1MKNK1 | |
| SCHEMBL23266636 | 0.81 | HTT (0.60) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL31072244 | 0.80 | HCAR1 (0.53) | HTTHCAR1POLBFGFR1 | |
| SCHEMBL23840256 | 0.79 | HTT (0.58) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL56852 | 0.79 | FGFR1 (0.61) | HTTPOLBFGFR1ALDH1A1 | |
| SCHEMBL23840275 | 0.78 | FGFR1 (0.58) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL7211112 | 0.78 | HTT (0.56) | HTTHCAR1POLBFGFR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1097618-B1 | POST-TREATMENT FOR COPPER ON PRINTED CIRCUIT BOARDS | FRYS METALS INC DBA ALPHA METALS INC (US) | 2003-03-26 | — | — | EP | claimed |
| US-12052915-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-30 | — | — | US | disclosed |
| US-11696492-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-11424420-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-08-23 | — | — | US | disclosed |
| US-20210119138-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
| CN-112670421-A | Organic electroluminescent device | 三星显示有限公司 | 2021-04-16 | — | — | CN | disclosed |
| US-20200220090-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-09 | — | — | US | disclosed |
| US-20190074455-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-07 | — | — | US | disclosed |
| US-9865952-B2 | Plug contact with organic coating and printed circuit board arrangement | CONTINENTAL AUTOMOTIVE GMBH (DE) | 2018-01-09 | — | — | US | disclosed |
| US-20170179628-A1 | PLUG CONTACT WITH ORGANIC COATING AND PRINTED CIRCUIT BOARD ARRANGEMENT | CONTINENTAL AUTOMOTIVE GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| EP-2991644-A2 | NONSTEROIDAL AND STEROIDAL COMPOUNDS WITH POTENT ANDROGEN RECEPTOR DOWN-REGULATION AND ANTI PROSTATE CANCER ACTIVITY | University of Maryland, Baltimore (US) | 2016-03-09 | — | — | EP | disclosed |
| EP-2935240-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014165815-A2 | NONSTEROIDAL AND STEROIDAL COMPOUNDS WITH POTENT ANDROGEN RECEPTOR DOWN-REGULATION AND ANTI PROSTATE CANCER ACTIVITY | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014100695-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-2493310-A1 | BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS | GlaxoSmithKline LLC (US) | 2012-09-05 | — | — | EP | disclosed |
| US-20120208827-A1 | BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC | 2012-08-16 | — | — | US | disclosed |
| WO-2011056635-A1 | BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20110046105-A1 | Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof | SANOFI-AVENTIS (FR) | 2011-02-24 | — | — | US | disclosed |
| EP-2242746-A1 | HETEROCYCLICALLY-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF | Sanofi-Aventis (FR) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009098000-A1 | HETEROCYCLICALLY-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF | SANOFI-AVENTIS (FR) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208827-A1 | BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS | FASN, FADS1, FADS2 | HTT 4048/4885HCAR1 857/4885POLB 1739/4885 |
| US-12052915-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | BMI1, L1CAM, EML4 | HTT 4388/4885HCAR1 4843/4885POLB 1851/4885 |
| US-20110046105-A1 | Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof | GIPR, DDC, PGC | HTT 1571/4885HCAR1 1633/4885POLB 2947/4885 |
| US-20200220090-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ODC1 | HTT 2667/4885HCAR1 4689/4885POLB 733/4885 |
| US-20190074455-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, SOD1, OR10J3 | HTT 3268/4885HCAR1 3993/4885POLB 1781/4885 |
| US-11696492-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, ODC1 | HTT 2667/4885HCAR1 4689/4885POLB 733/4885 |
| US-11424420-B2 | Organic electroluminescent materials and devices | L1CAM, SOD1, OR10J3 | HTT 3268/4885HCAR1 3993/4885POLB 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.